Progenics Pharma (PGNX)

6.41 -0.16 (2.44%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/2/18 *Est.)

Latest Headlines

Progenics Pharma (PGNX) Reports Addition of AZEDRA (iobenguane I 131) to National Comprehensive Cancer Network Guidelines for Pheochromocytoma and Paraganglioma September 17, 2018 6:02 AM - StreetInsider Progenics Announces Addition of AZEDRA® (iobenguane I 131) to National Comprehensive Cancer Network Guidelines for Pheochromocytoma and Paraganglioma September 17, 2018 6:00 AM - Globe NewsWire Progenics Announces Addition of AZEDRA® (iobenguane I 131) to National Comprehensive Cancer Network Guidelines for Pheochromocytoma and Paraganglioma September 17, 2018 6:00 AM - StreetInsider Progenics Pharmaceuticals (PGNX) Sell-Off 'Seems Overdone' - BTIG September 13, 2018 11:53 AM - StreetInsider Needham & Company Downgrades Progenics Pharmaceuticals (PGNX) to Buy September 13, 2018 11:30 AM - StreetInsider Pre-Open Movers 09/13: (PI) (XBIT) (GNC) Higher; (PVTL) (PGNX) (FRED) Lower (more...) September 13, 2018 9:17 AM - StreetInsider After-Hours Stock Movers 09/12: (PI) (TLRD) Higher; (PVTL) (PGNX) (SRTS) Lower (more...) September 12, 2018 6:15 PM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Sep 12 September 12, 2018 4:16 PM - SEC Filing Progenics Pharma (PGNX) Phase 3 Study for Prostate Cancer Imaging Agent 1404 Doesn't Meet Primary Endpoint September 12, 2018 4:01 PM - StreetInsider Progenics Pharmaceuticals Reports Top Line Phase 3 Data for Prostate Cancer Imaging Agent 1404 September 12, 2018 4:01 PM - Globe NewsWire Progenics Pharmaceuticals Reports Top Line Phase 3 Data for Prostate Cancer Imaging Agent 1404 September 12, 2018 4:01 PM - StreetInsider Progenics Pharma (PGNX) Halted, News Pending September 12, 2018 4:00 PM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Aug 07 August 10, 2018 4:20 PM - SEC Filing Form 424B5 PROGENICS PHARMACEUTICAL August 8, 2018 4:13 PM - SEC Filing Progenics Pharma (PGNX) Prices 9.09M Share Common Offering at $8.25/Sh August 8, 2018 5:40 AM - StreetInsider Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock August 7, 2018 10:13 PM - StreetInsider Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock August 7, 2018 10:12 PM - Globe NewsWire Form 8-K PROGENICS PHARMACEUTICAL For: Aug 07 August 7, 2018 5:00 PM - SEC Filing Form 424B5 PROGENICS PHARMACEUTICAL August 7, 2018 4:43 PM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Aug 07 August 7, 2018 4:41 PM - SEC Filing Progenics Pharma (PGNX) to Offer Common Stock August 7, 2018 4:06 PM - StreetInsider Progenics Pharmaceuticals Announces Proposed Public Offering of Common Stock August 7, 2018 4:01 PM - Globe NewsWire Progenics Pharmaceuticals Announces Proposed Public Offering of Common Stock August 7, 2018 4:01 PM - StreetInsider Increasing unusual put option volume: CRTO GDS TDOS PGNX QEP ZTS August 1, 2018 5:13 AM - StreetInsider Form 10-Q PROGENICS PHARMACEUTICAL For: Jun 30 July 31, 2018 5:19 PM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Jul 31 July 31, 2018 5:19 PM - SEC Filing Following Azedra’s Approval, Progenics Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update July 31, 2018 4:30 PM - Globe NewsWire Following Azedra’s Approval, Progenics Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update July 31, 2018 4:30 PM - StreetInsider Progenics Pharmaceuticals (PGNX) PT Raised to $16 at Needham & Company July 31, 2018 1:54 PM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Jul 30 July 31, 2018 6:13 AM - SEC Filing Progenics Pharma (PGNX) Confirms FDA Approval for AZEDRA (iobenguane I 131) July 31, 2018 5:44 AM - StreetInsider Progenics Pharmaceuticals Announces FDA Approval for AZEDRA® (iobenguane I 131) to Treat Unresectable, Locally Advanced or Metastatic Pheochromocytoma or Paraganglioma July 30, 2018 9:47 PM - StreetInsider Progenics Pharmaceuticals Announces FDA Approval for AZEDRA® (iobenguane I 131) to Treat Unresectable, Locally Advanced or Metastatic Pheochromocytoma or Paraganglioma July 30, 2018 9:46 PM - Globe NewsWire FDA Approves Progenics Pharma's (PGNX) AZEDRA July 30, 2018 3:11 PM - StreetInsider Progenics Pharma (PGNX) call put ratio 3.4 calls to 1 put with focus on August 10 calls into halt on news pending July 30, 2018 3:06 PM - StreetInsider Progenics Pharma (PGNX) Halted on LUDP/Halted News Pending July 30, 2018 3:03 PM - StreetInsider Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: FEDERATED INVESTORS INC /PA/ July 10, 2018 11:40 AM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Jun 28 July 3, 2018 4:03 PM - SEC Filing Form S-8 PROGENICS PHARMACEUTICAL June 28, 2018 4:08 PM - SEC Filing Form S-8 POS PROGENICS PHARMACEUTICAL June 28, 2018 4:07 PM - SEC Filing Form S-8 POS PROGENICS PHARMACEUTICAL June 28, 2018 4:06 PM - SEC Filing Form S-8 POS PROGENICS PHARMACEUTICAL June 28, 2018 4:05 PM - SEC Filing Form S-8 POS PROGENICS PHARMACEUTICAL June 28, 2018 4:05 PM - SEC Filing Form S-8 POS PROGENICS PHARMACEUTICAL June 28, 2018 4:05 PM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Jun 25 June 26, 2018 4:03 PM - SEC Filing Progenics Pharma (PGNX) Completes Enrollment of Phase 2/3 Clinical Trial of PSMA-Targeted PET/CT Imaging Agent PyL in Prostate Cancer June 26, 2018 8:35 AM - StreetInsider Progenics Pharmaceuticals Completes Enrollment of Phase 2/3 Clinical Trial of PSMA-Targeted PET/CT Imaging Agent PyL™ in Prostate Cancer June 26, 2018 8:30 AM - Globe NewsWire Progenics Pharmaceuticals Completes Enrollment of Phase 2/3 Clinical Trial of PSMA-Targeted PET/CT Imaging Agent PyL™ in Prostate Cancer June 26, 2018 8:30 AM - StreetInsider Progenics Pharmaceuticals Presents Data Validating its Artificial Intelligence Imaging Analysis Technology for Use with PSMA-Targeted SPECT/CT June 25, 2018 8:30 AM - Globe NewsWire Progenics Pharmaceuticals Presents Data Validating its Artificial Intelligence Imaging Analysis Technology for Use with PSMA-Targeted SPECT/CT June 25, 2018 8:30 AM - StreetInsider Full Article List